These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 1230245)
1. The present status of trachoma in the Eastern Mediterranean Region. Maichuk Y Bull Ophthalmol Soc Egypt; 1975; 68():51-4. PubMed ID: 1230245 [No Abstract] [Full Text] [Related]
2. Trachoma control in the Eastern Mediterranean Region. Majcuk J WHO Chron; 1976 Mar; 30(3):97-100. PubMed ID: 1258465 [No Abstract] [Full Text] [Related]
3. Evaluation of treatment against trachoma in two regions of Ethiopia. Cerulli L; Cedrone C; Assefa C; Scuderi GL Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1983; ():67-83. PubMed ID: 6680241 [No Abstract] [Full Text] [Related]
4. Prevention and treatment of trachoma and the anti-blindness program. Nguyen DH Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1991; 68():171-7. PubMed ID: 1669648 [TBL] [Abstract][Full Text] [Related]
5. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Lietman T; Porco T; Dawson C; Blower S Nat Med; 1999 May; 5(5):572-6. PubMed ID: 10229236 [TBL] [Abstract][Full Text] [Related]
6. Towards the global elimination of trachoma. Taylor H Nat Med; 1999 May; 5(5):492-3. PubMed ID: 10229224 [No Abstract] [Full Text] [Related]
7. Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma. Fraser-Hurt N; Bailey RL; Cousens S; Mabey D; Faal H; Mabey DC Bull World Health Organ; 2001; 79(7):632-40. PubMed ID: 11477966 [TBL] [Abstract][Full Text] [Related]
8. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Fry AM; Jha HC; Lietman TM; Chaudhary JS; Bhatta RC; Elliott J; Hyde T; Schuchat A; Gaynor B; Dowell SF Clin Infect Dis; 2002 Aug; 35(4):395-402. PubMed ID: 12145722 [TBL] [Abstract][Full Text] [Related]
11. Preventable blindness in the east African elderly. Wood ML East Afr Med J; 1997 Oct; 74(10):639-41. PubMed ID: 9529745 [TBL] [Abstract][Full Text] [Related]
12. [The methodology and focus in blindness prevention from an epidemiologic point of view]. Wei ZX Zhonghua Yan Ke Za Zhi; 1989 Nov; 25(6):365-7. PubMed ID: 2627863 [TBL] [Abstract][Full Text] [Related]
13. The prevention of blindness from trachoma. Schachter J Int Ophthalmol; 1988; 12(1):3-4. PubMed ID: 3220665 [No Abstract] [Full Text] [Related]
15. Elimination of trachoma: follow up. De Sole G Br J Ophthalmol; 1998 May; 82(5):590. PubMed ID: 9713077 [No Abstract] [Full Text] [Related]
16. Trachoma in eastern province of Saudi Arabia. Chandra G Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1992; 69():118-32. PubMed ID: 1344965 [TBL] [Abstract][Full Text] [Related]
17. [Current epidemiologic profile of trachoma in Tunisia. Results of an evaluation of the program of prevention of blindness]. Daghfous MT; Djerad A; Fakhfakh H; Bouzidi F; Ben Osman N Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique; 1989; 66(3-4):157-61. PubMed ID: 2488662 [TBL] [Abstract][Full Text] [Related]
18. The trachoma status and blindness rates of selected areas of Papua New Guinea in 1979-80. Dethlefs R Aust J Ophthalmol; 1982 Feb; 10(1):13-8. PubMed ID: 7103858 [TBL] [Abstract][Full Text] [Related]
20. Trachoma and cataract: two WHO targets. Maitchouk IF Int Nurs Rev; 1985; 32(1):23-5. PubMed ID: 3844389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]